Cell-Type-Specific Activation and Repression of PU.1 by a Complex of Discrete, Functionally Specialized cis-Regulatory Elements
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The transcription factor PU.1 is critical for multiple hematopoietic lineages, but different leukocyte types require strictly distinct patterns of PU.1 regulation. PU.1 is required early for T-cell lineage development but then must be repressed by a stage-specific mechanism correlated with commitment. Other lineages require steady, low expression or upregulation. Until now, only the promoter plus a distal upstream regulatory element (URE) could be invoked to explain nearly all Sfpi1 (PU.1) activation and repression, including bifunctional effects of Runx1. However, the URE is dispensable for most Sfpi1 downregulation in early T cells, and we show that it retains enhancer activity in immature T-lineage cells even where endogenous Sfpi1 is repressed. We now present evidence for another complex of conserved noncoding elements that mediate discrete, cell-type-specific regulatory features of Sfpi1, including a myeloid cell-specific activating element and a separate, pro-T-cell-specific silencer element. These elements yield opposite, cell-type-specific responses to Runx1. T-cell-specific repression requires Runx1 acting through multiple nonconsensus sites in the silencer core. These newly characterized sites recruit Runx1 binding in early T cells in vivo and define a functionally specific scaffold for dose-dependent, Runx-mediated repression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The best current candidates for this silencing activity include GATA-3 (104, 105), TCF-1 or LEF-1 (37), and especially Runx1 (80, 150–152), probably working in a dose-dependent combination, although the mechanism through which they finally achieve the ability to repress PU.1 has not yet been reported.”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [152]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PU.1 has been previously linked to proliferation in macrophages. Bone-marrow derived Macrophages over-expressing PU.1 increased GM-CSF and M-CSF dependent proliferation and cell number, the opposite was seen in cells transfected with an anti-sense PU.19.”
From Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease (2021) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“1 is essential for the development of myeloid and lymphoid lineages (22, 30), but inappropriately controlled expression can cause severe developmental defects and/or malignancy.”
BackgroundTargeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 1×
“1 is essential for the development of myeloid and lymphoid lineages (22, 30), but inappropriately controlled expression can cause severe developmental defects and/or malignancy.”
BackgroundmicroRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells
Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.009 · Cited by 763 · cited 1×
“1 expression, such as antisense transcription (11) and miRNA suppression (36), have explained only modest differences in the level, inadequate to account for the 2 to 3 orders of magnitude of repression that Sfpi1 undergoes during T-lineage commitment.”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730 · cited 3×
“1 expression is silenced during the transition to the DN3 stage of T-cell development, as the cells undergo lineage commitment (3, 33, 35).”
BackgroundAcute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“1 expression within hematopoietic cells nor fully blocked T-cell silencing (28, 29).”
BackgroundLoss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3280 · Cited by 462 · cited 2×
“In T-lineage cells, deletion of Runx1 produces a developmental block at the DN2 stage (13, 18), and the surviving cells have higher PU.”
BackgroundLaiosa, C. V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L., & Graf, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.011 · Cited by 351 · cited 1×
“2C2, can also cause the cells to gain myeloid characteristics (2, 10, 19), linking the silencing of PU.”
BackgroundDynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041535 · Cited by 325 · cited 1×
“1 expression is silenced in erythroid cells but elevated in macrophages, continues at moderately high levels in neutrophils and most types of dendritic cells, and is fixed at lower levels in committed B cells (4, 24).”
BackgroundTaghon, T., Yui, M. A., Pant, R., Diamond, R. A., & Rothenberg, E. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.012 · Cited by 312 · cited 1×
“Therefore, the binding of Runx proteins to CE4A was confirmed by competition in gel shifts against a validated Runx-dependent silencer sequence, the Cd4 silencer (32) (Fig.”
BackgroundSelf-citation
Cited by
Developmental gene networks: a triathlon on the course to T cell identity
Yui, M. A., & Rothenberg, E. V. (2014) · Nature Reviews Immunology · doi:10.1038/nri3702 · Cited by 342
Self-citationZhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J., & Rothenberg, E. V. (2012) · Cell · doi:10.1016/j.cell.2012.01.056 · Cited by 337
“H3Ac disappeared from the promoter while H3K4me2 marks in the upstream cis-regulatory elements of the gene (Rosenbauer et al., 2006; Zarnegar et al., 2010) narrowed as transcription declined (Fig.”
Self-citationPositive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation
Kueh, H. Y., Champhekar, A., Nutt, S. L., Elowitz, M. B., & Rothenberg, E. V. (2013) · Science · doi:10.1126/science.1240831 · Cited by 273
“1 transcription during lymphoid and myeloid development [7, 10-14].”
Self-citationHow transcription factors drive choice of the T cell fate
Hosokawa, H., & Rothenberg, E. V. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00426-6 · Cited by 247
Self-citationTranscriptional Control of Early T and B Cell Developmental Choices
Rothenberg, E. V. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100024 · Cited by 215
Self-citationAsynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment
Kueh, H. Y., Yui, M. A., Ng, K. K. H., Pease, S. S., Zhang, J. A., Damle, S. S., Freedman, G., Siu, S., Bernstein, I. D., Elowitz, M. B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3514 · Cited by 141
Self-citationTwo distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
“1 locus was found using a manual mapping approach.(44) The only PU.”
MethodHosokawa, H., Ungerbäck, J., Wang, X., Matsumoto, M., Nakayama, K. I., Cohen, S. M., Tanaka, T., & Rothenberg, E. V. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.024 · Cited by 116
Self-citationA far downstream enhancer for murine Bcl11b controls its T-cell specific expression
Li, L., Zhang, J. A., Dose, M., Kueh, H. Y., Mosadeghi, R., Gounari, F., & Rothenberg, E. V. (2013) · Blood · doi:10.1182/blood-2012-08-447839 · Cited by 117
Self-citationMechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
Self-citationT Cell Lineage Commitment: Identity and Renunciation
Rothenberg, E. V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003703 · Cited by 89
“1) gene appear to mediate repression: a multifunctional Upstream Regulatory Element (48,49), and a recently described, cell-type specific silencer (50).”
BackgroundSelf-citationBcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network
Longabaugh, W. J. R., Zeng, W., Zhang, J. A., Hosokawa, H., Jansen, C. S., Li, L., Romero-Wolf, M., Liu, P., Kueh, H. Y., Mortazavi, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610617114 · Cited by 89
Self-citationMontecino-Rodriguez, E., Fice, M., Casero, D., Berent-Maoz, B., Barber, C. L., & Dorshkind, K. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.012 · Cited by 87
“This is achieved through the binding of specific combinations of transcription factors that include Runx1, Sfpi1, Ikzf, and/or Foxo1 to multiple Sfpi1 cis-regulatory elements (Leddin et al., 2011; Okuno et al., 2005; Zarnegar et al., 2010).”
BackgroundMultilayered specification of the T-cell lineage fate.
Rothenberg, E. V., Zhang, J., & Li, L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00964.x · Cited by 81
“Therefore, the Notch signals that turn on CD25 and activate GATA-3 and TCF-1 and initiate Bcl11b induction are not in themselves sufficient to dictate the repression of the progenitor-cell genes.”
BackgroundInfluentialSelf-citationGATA-3 Dose-Dependent Checkpoints in Early T Cell Commitment
Scripture-Adams, D. D., Damle, S. S., Li, L., Elihu, K. J., Qin, S., Arias, A. M., Butler, R. R., Champhekar, A., Zhang, J. A., & Rothenberg, E. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301663 · Cited by 81
“7 cells were transfected as described previously (23, 30).”
MethodSelf-citationCytokines, Transcription Factors, and the Initiation of T-Cell Development
Hosokawa, H., & Rothenberg, E. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028621 · Cited by 98
“The silencing of Sfpi1 expression, through a mechanism dependent on RUNX factors and possibly GATA3 (Taghon et al. 2007; Huang et al. 2008; Zarnegar et al. 2010; Scripture-Adams et al. 2014), is thought to be one of the molecular mechanisms of alternative lineage exclusion as noted above.”
BackgroundSelf-citationProgramming for T-lymphocyte fates: modularity and mechanisms
Rothenberg, E. V. (2019) · Genes & Development · doi:10.1101/gad.327163.119 · Cited by 80
“However, both gain- and loss-of-function experiments clearly show that GATA3 (Taghon et al. 2007; Scripture-Adams et al. 2014) and Runx1 (Hoogenkamp et al. 2007; Huang et al. 2008; Zarnegar et al. 2010; Hosokawa et al. 2018b) participate in the repression of Spi1 around the time of commitment.”
BackgroundSelf-citationAlcina, A., Fedetz, M., Fernández, Ó., Saiz, A., Izquierdo, G., Lucas, M., Leyva, L., García-León, J.-A., Abad-Grau, M. D. M., Alloza, I., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101085 · Cited by 69
“Although it could seem contradictory that one enhancer may differentially affect the expression of different genes, parallel situations have been described extensively in two scenarios: first, the same transcription factor is capable of activating or repressing depending on the context;(32) 33 second, a single DNA seq…”
BackgroundRothenberg, E. V., Ungerbäck, J., & Champhekar, A. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.09.002 · Cited by 61
Self-citationOn becoming a T cell, a convergence of factors kick it up a Notch along the way
Thompson, P. K., & Zúñiga‐Pflücker, J. C. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.007 · Cited by 66
“1 promoter sequences, the atter of which must be occupied by Runx1 in order to suppress -lineage and promote myeloid development [106].”
BackgroundInfluentialFGFR3 is a target of the homeobox transcription factor SHOX in limb development
Decker, E., Durand, C., Bender, S., Rödelsperger, C., Glaser, A., Hecht, J., Schneider, K., & Rappold, G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr030 · Cited by 62
Epigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 48
Regulatory gene network circuits underlying T cell development from multipotent progenitors
Kueh, H. Y., & Rothenberg, E. V. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.162 · Cited by 41
“The data sources used for this T-cell network reconstruction are listed in Supplementary Table 1, together with the approaches used to evaluate regulatory network linkages in each study [28, 35, 42, 44, 52-96].”
Self-citationJones, R. E., Andrews, R., Holmans, P., Hill, M., & Taylor, P. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-94324-z · Cited by 39
Hematopoiesis and T‐cell specification as a model developmental system
Rothenberg, E. V., Kueh, H. Y., Yui, M. A., & Zhang, J. A. (2016) · Immunological Reviews · doi:10.1111/imr.12417 · Cited by 36
Self-citationZarnegar, M. A., & Rothenberg, E. V. (2012) · Oncogene · doi:10.1038/onc.2011.597 · Cited by 38
“Additional myeloid-specific enhancers have also been found between the URE and the promoter (14, 15).”
Self-citationFerrell, P. I., Xi, J., Ma, C., Adlakha, M., & Kaufman, D. S. (2014) · Stem Cells · doi:10.1002/stem.1940 · Cited by 26
Willcockson, M. A., Taylor, S. J., Ghosh, S., Healton, S. E., Wheat, J. C., Wilson, T. J., Steidl, U. G., & Skoultchi, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901122116 · Cited by 26
“1 URE in a cell-type–specific manner in B cells (13, 16), T cells (21), and myeloid cells (13, 15).”
BackgroundStage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro–T cells
Hosokawa, H., Koizumi, M., Masuhara, K., Romero-Wolf, M., Tanaka, T., Nakayama, T., & Rothenberg, E. V. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202648 · Cited by 24
“Therefore, Runx1 and GATA3 may be involved in establishment of stage-specific repressive chromatin looping architectures around the Spi1 locus, including the +3.7-kb, +145-kb, and CE4 elements.”
BackgroundInfluentialSelf-citationDNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation
Fernández-Nestosa, M. J., Monturus, E., Sánchez, Z., Torres, F. S., Fernández, A. F., Fraga, M. F., Hernández, P., Schvartzman, J. B., & Krimer, D. B. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-392 · Cited by 20
Montecino-Rodriguez, E., Casero, D., Fice, M., Le, J., & Dorshkind, K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701336 · Cited by 17
“2B, 2C), it is likely that the cells analyzed in the previous study (20) were non–T lineage cells able to express Spi1 independently of the 14-kb URE (35).”
BackgroundDynamic control of the T-cell specification gene regulatory network
Rothenberg, E. V. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.10.012 · Cited by 17
Self-citationOlariu, V., Yui, M. A., Krupinski, P., Zhou, W., Deichmann, J., Andersson, E., Rothenberg, E. V., & Peterson, C. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108622 · Cited by 15
Self-citationRothenberg, E. V., Champhekar, A. S., Damle, S. S., Real, M. M. D., Kueh, H. Y., Li, L., & Yui, M. A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020271 · Cited by 17
“At least in part this is because they become engaged at a T-lineage-specific silencer element that may quench the activation effects of the major Sfpi1 enhancer (Zarnegar et al. 2010; Zarnegar and Rothenberg 2012).”
BackgroundSelf-citationLogical modeling of cell fate specification—Application to T cell commitment
Cacace, E., Collombet, S., & Thieffry, D. (2020) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2020.02.008 · Cited by 11
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation
Ahmed, N., Etzrodt, M., Dettinger, P., Kull, T., Loeffler, D., Hoppe, P. S., Chavez, J. S., Zhang, Y., Camargo Ortega, G., Hilsenbeck, O., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20202490 · Cited by 9
Korczmar, E., Bookstaver, A. K., Ober, E., Goldfarb, A. N., Tenen, D. G., & Trinh, B. Q. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1602010 · Cited by 9
Jenkins, C. E., Gusscott, S., Wong, R. J., Shevchuk, O. O., Rana, G., Giambra, V., Tyshchenko, K., Islam, R., Hirst, M., & Weng, A. P. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.04.008 · Cited by 9
Manesso, E., Kueh, H. Y., Freedman, G., Rothenberg, E. V., & Peterson, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161260 · Cited by 9
Self-citationQiu, K., Vu, D. C., Wang, L., Nguyen, N. N., Bookstaver, A. K., Sol‐Church, K., Li, H., Dinh, T. N., Goldfarb, A. N., Tenen, D. G., et al. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00556-4 · Cited by 7
“CE5 induces transient Pu.1 promoter activity in murine macrophages [22].”
BackgroundMethodInfluentialRothenberg, E. V., & Göttgens, B. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000628 · Cited by 6
Self-citationHosokawa, H., Masuhara, K., & Koizumi, M. (2021) · BioEssays · doi:10.1002/bies.202000345 · Cited by 7
Enhancers in T Cell development and malignant lesions
Zhang, T., & Zou, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02160-7 · Cited by 3
Wang, M., Wang, J., Zhang, X., & Yuan, R. (2021) · Royal Society Open Science · doi:10.1098/rsos.211289 · Cited by 3
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 3
“(Zarnegar et al., 2010) recently uncovered a set of conserved cisregulatory regions for Spi-1.”
BackgroundGATA3 regulates Th1/Th2 balance in allergic rhinitis by interacting with RUNX1
Li, Y., Wang, T., He, M., Wang, Y., & He, J. (2025) · Future Science OA · doi:10.1080/20565623.2025.2541503 · Cited by 1
“Research has confirmed that the multiple non-consensus sites of RUNX1 are necessary for inhibitor t cells [30]. hosokawa et al confirm that RUNX1 can combine Gata3 in DN2b/3 stage-specific of the spi1 locus [31].”
Epigenetic PU.1 silencing in myeloid leukemia by mimicrying a T cell specific chromatin loop
Perrod, C. (2013) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/16863 · Cited by 1
“1 promoter, with different dynamics throughout hematopoietic cell types (Leddin et al., 2011; Zarnegar et al., 2010).”
BackgroundInfluentialReal, D. (2013) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/pews-km18
Transcriptional Regulation of T Cell Lineage Commitment
Rothenberg, E. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.04006-6
Self-citationJones, R. E., Hill, M., & Taylor, P. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17705.1
Transcriptional Regulation of T-Cell Lineage Commitment
Rothenberg, E. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00018-1
Self-citation
Metadata
- Authors
- Zarnegar, M. A., Chen, J., & Rothenberg, E. V.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Rothenberg, Ellen V.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-10-01
- Volume
- 30
- Issue
- 20
- Pages
- 4922-4939
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2950536
- OpenAlex
- W2016316813
- Cited by
- 52
- References
- 38
- Citations by year
- 2025: 1 · 2024: 5 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Cancer Institute (R01CA090233)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073658)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, RUNX1, cis-regulatory elements, enhancers, silencers, myeloid cells, transcriptional repression, transcriptional activation, hematopoietic lineage specification, cell type-specific gene regulation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Base Sequence, Binding Sites, Cell Differentiation, Cell Line, Deoxyribonucleases, DNA, Enhancer Elements, Genetic, Genetic Complementation Test, Models, Biological, Molecular Sequence Data, Proto-Oncogene Proteins, Sequence Homology, Nucleic Acid, T-Lymphocytes, Trans-Activators, Conserved Sequence, Regulatory Elements, Transcriptional, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.